The latest closing stock price for Organogenesis as of June 02, 2025 is 2.66.
An investor who bought $1,000 worth of Organogenesis stock at the IPO in 2017 would have $-727 today, roughly -1 times their original investment - a -14.99% compound annual growth rate over 8 years.
The all-time high Organogenesis stock closing price was 150.00 on January 11, 2019.
The Organogenesis 52-week high stock price is 6.71, which is 152.3% above the current share price.
The Organogenesis 52-week low stock price is 2.28, which is 14.3% below the current share price.
The average Organogenesis stock price for the last 52 weeks is 3.43.
An investor who bought $1,000 worth of Organogenesis stock at the IPO in 2017 would have $-727 today, roughly -1 times their original investment - a -14.99% compound annual growth rate over 8 years.
The all-time high Organogenesis stock closing price was 150.00 on January 11, 2019.
The Organogenesis 52-week high stock price is 6.71, which is 152.3% above the current share price.
The Organogenesis 52-week low stock price is 2.28, which is 14.3% below the current share price.
The average Organogenesis stock price for the last 52 weeks is 3.43.